Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker PGEN
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | SCHEDULE 13G/A (amended) | PGEN Precigen, Inc. | E. Merck KG, Darmstadt Germany | 17.47M | 4.9% | SCHEDULE 13G/A ↗ |
| Aug 7, 2026 | SCHEDULE 13G/A (amended) | PGEN Precigen, Inc. | Merck KGaA, Darmstadt, Germany | 17.47M | 4.9% | SCHEDULE 13G/A ↗ |
| Aug 7, 2026 | SCHEDULE 13G/A (amended) | PGEN Precigen, Inc. | Merck Serono SA, Aubonne, Switzerland, an affiliate of Merck KGaA, Darmstadt | 17.47M | 4.9% | SCHEDULE 13G/A ↗ |
| Aug 7, 2026 | SCHEDULE 13G/A (amended) | PGEN Precigen, Inc. | Ares Trading SA | 17.47M | 4.9% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | PGEN Precigen, Inc. | Steven A. Cohen | 6.74M | 1.9% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | PGEN Precigen, Inc. | Point72 Capital Advisors, Inc. | 6.74M | 1.9% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | PGEN Precigen, Inc. | Point72 Asset Management, L.P. | 6.74M | 1.9% | SCHEDULE 13G/A ↗ |
| Mar 31, 2026 | SCHEDULE 13D/A (amended) | PGEN Precigen, Inc. | Third Security, LLC | 21.84M | 5.9% | SCHEDULE 13D/A ↗ |
| Mar 31, 2026 | SCHEDULE 13D/A (amended) | PGEN Precigen, Inc. | R.J. Kirk Declaration of Trust | 97.34M | 26.1% | SCHEDULE 13D/A ↗ |
| Mar 31, 2026 | SCHEDULE 13D/A (amended) | PGEN Precigen, Inc. | Randal J. Kirk | 133.96M | 35.9% | SCHEDULE 13D/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | PGEN Precigen, Inc. | Patient Opportunity Trust, a Series of Advisor Managed Portfolios | 27.62M | 7.8% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | PGEN Precigen, Inc. | Patient Capital Management, LLC | 36.01M | 10.2% | SCHEDULE 13G/A ↗ |
| Jan 23, 2026 | SCHEDULE 13G | PGEN Precigen, Inc. | Steven A. Cohen | 18.38M | 5.2% | SCHEDULE 13G ↗ |
| Jan 23, 2026 | SCHEDULE 13G | PGEN Precigen, Inc. | Point72 Capital Advisors, Inc. | 18.38M | 5.2% | SCHEDULE 13G ↗ |
| Jan 23, 2026 | SCHEDULE 13G | PGEN Precigen, Inc. | Point72 Asset Management, L.P. | 18.38M | 5.2% | SCHEDULE 13G ↗ |
| Nov 21, 2025 | SCHEDULE 13D/A (amended) | PGEN Precigen, Inc. | Third Security, LLC | 24.49M | 6.6% | SCHEDULE 13D/A ↗ |
| Nov 21, 2025 | SCHEDULE 13D/A (amended) | PGEN Precigen, Inc. | R.J. Kirk Declaration of Trust | 98.83M | 26.6% | SCHEDULE 13D/A ↗ |
| Nov 21, 2025 | SCHEDULE 13D/A (amended) | PGEN Precigen, Inc. | Randal J. Kirk | 141.52M | 38.1% | SCHEDULE 13D/A ↗ |
| Oct 30, 2025 | SCHEDULE 13G/A (amended) | PGEN Precigen, Inc. | Patient Opportunity Trust, a Series of Advisor Managed Portfolios | 35.79M | 11.0% | SCHEDULE 13G/A ↗ |
| Oct 30, 2025 | SCHEDULE 13G/A (amended) | PGEN Precigen, Inc. | Patient Capital Management, LLC | 45.22M | 13.6% | SCHEDULE 13G/A ↗ |
| Sep 23, 2025 | SCHEDULE 13G | PGEN Precigen, Inc. | William H. Miller III Living Trust dated April 17, 2017 | 34.05M | 9.2% | SCHEDULE 13G ↗ |
| Sep 19, 2025 | SCHEDULE 13D/A (amended) | PGEN Precigen, Inc. | Third Security, LLC | 27.45M | 7.4% | SCHEDULE 13D/A ↗ |
| Sep 19, 2025 | SCHEDULE 13D/A (amended) | PGEN Precigen, Inc. | Sunset 2020 LLC | 16.41M | 4.4% | SCHEDULE 13D/A ↗ |
| Sep 19, 2025 | SCHEDULE 13D/A (amended) | PGEN Precigen, Inc. | R.J. Kirk Declaration of Trust | 98.83M | 26.6% | SCHEDULE 13D/A ↗ |
| Sep 19, 2025 | SCHEDULE 13D/A (amended) | PGEN Precigen, Inc. | Randal J. Kirk | 146.30M | 39.4% | SCHEDULE 13D/A ↗ |
| Feb 12, 2025 | SCHEDULE 13G/A (amended) | PGEN Precigen, Inc. | Patient Capital Management, LLC | 17.68M | 6.5% | SCHEDULE 13G/A ↗ |
| Dec 30, 2024 | SCHEDULE 13D/A (amended) | PGEN Precigen, Inc. | Third Security, LLC | 32.45M | 11.1% | SCHEDULE 13D/A ↗ |
| Dec 30, 2024 | SCHEDULE 13D/A (amended) | PGEN Precigen, Inc. | Sunset 2020 LLC | 16.41M | 5.6% | SCHEDULE 13D/A ↗ |
| Dec 30, 2024 | SCHEDULE 13D/A (amended) | PGEN Precigen, Inc. | R.J. Kirk Declaration of Trust | 64.55M | 22.0% | SCHEDULE 13D/A ↗ |
| Dec 30, 2024 | SCHEDULE 13D/A (amended) | PGEN Precigen, Inc. | Randal J. Kirk | 116.84M | 39.8% | SCHEDULE 13D/A ↗ |
30 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 8:17 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances